aav expressing shctrl (Vigene Biosciences)
90
Structured Review
Vigene Biosciences
aav expressing shctrl
Aav Expressing Shctrl, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav-shctrl/aav+expressing+shctrl/pm37858471-212-12-24
Average 90 stars, based on 1 article reviews
Aav Expressing Shctrl, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav-shctrl/aav+expressing+shctrl/pm37858471-212-12-24
Average 90 stars, based on 1 article reviews
aav expressing shctrl - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Mouse Assay:Article Title: m 6 A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Article Snippet: .. Mice bearing PDXs were administered two intratumoral injections, at 3-day intervals, with Article Title: m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell cycle progression and HIF-1α activation Article Snippet: .. Mice bearing PDXs were injected intratumorally twice at 3-day intervals with Bioprocessing:Article Title: m 6 A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Article Snippet: .. Mice bearing PDXs were administered two intratumoral injections, at 3-day intervals, with Article Title: m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell cycle progression and HIF-1α activation Article Snippet: .. Mice bearing PDXs were injected intratumorally twice at 3-day intervals with Expressing:Article Title: m 6 A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Article Snippet: .. Mice bearing PDXs were administered two intratumoral injections, at 3-day intervals, with Article Title: m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell cycle progression and HIF-1α activation Article Snippet: .. Mice bearing PDXs were injected intratumorally twice at 3-day intervals with Produced:Article Title: m 6 A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Article Snippet: .. Mice bearing PDXs were administered two intratumoral injections, at 3-day intervals, with Article Title: m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell cycle progression and HIF-1α activation Article Snippet: .. Mice bearing PDXs were injected intratumorally twice at 3-day intervals with other:Article Title: HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Article Snippet: The PDX models were established with NOD-Prkdcscid-Il2rgem1IDMO (NPI) mice (IDMO, Beijing, China) as previously described.49 Article Title: HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity Article Snippet: Injection:Article Title: m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell cycle progression and HIF-1α activation Article Snippet: .. Mice bearing PDXs were injected intratumorally twice at 3-day intervals with |